Skip to main content

Advertisement

Table 4 Stratified analysis of melanoma recurrence risk by type of immunotherapy (immune biologics and vaccines) in the patients who had primary adjuvant immunotherapy

From: Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy

  MMP-23 composite score
Immune biologicsa Vaccinesb
0 - 2 3 - 4 0 - 2 3 - 4
Recurrence     
Yes 1 (25%) 13 (87%) 4 (57%) 10 (71%)
No 3 (75%) 2 (23%) 3 (43%) 4 (29%)
Total 4 (100%) 15 (100%) 7 (100%) 14 (100%)
  1. a P = 0.037; b P = 0.64.